Who invested in GlyCardial Diagnostics?
GlyCardial Diagnostics's investors include EISMEA, Horizon 2020 and EIT Health.
Who invested in GlyCardial Diagnostics
Funding summaryUpdated 26 Oct 2026
$2.2Mraised across 1 round since 2019, from 1 source
- Latest round
- Grant, $2.2MJan 2019
- Investors
- 3
The rounds
- Jan 2019
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about GlyCardial Diagnostics
How much has GlyCardial Diagnostics raised?
GlyCardial Diagnostics has raised $2.2M across 1 round since 2019.
When did GlyCardial Diagnostics last raise?
GlyCardial Diagnostics's most recent round was a Grant of $2.2M in Jan 2019.
What was GlyCardial Diagnostics's biggest round?
Its most recent round, $2.2M in Jan 2019, is also its largest on record.
Who backed GlyCardial Diagnostics first?
GlyCardial Diagnostics's first round on record, in Jan 2019, was backed by EISMEA, Horizon 2020 and EIT Health.
What stage is GlyCardial Diagnostics at?
GlyCardial Diagnostics's latest named round is a Grant, in Jan 2019.
Companies like GlyCardial Diagnostics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.